國立虎尾科技大學 |

Sigma proteins = evolution of the concept of Sigma receptors /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Sigma proteins/ edited by Felix J. Kim, Gavril W. Pasternak.
Reminder of title:	evolution of the concept of Sigma receptors /
other author:	Kim, Felix J.
Published:	Cham :Springer International Publishing : : 2017.,
Description:	viii, 330 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Sigma receptors. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-65853-7
ISBN:	9783319658537

Sigma proteins = evolution of the concept of Sigma receptors /
Sigma proteinsevolution of the concept of Sigma receptors /[electronic resource] :edited by Felix J. Kim, Gavril W. Pasternak. - Cham :Springer International Publishing :2017. - viii, 330 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2440171-2004 ;. - Handbook of experimental pharmacology ;v.212..

Preface -- Historical perspective and background - including Sigma protein subtypes and ligand selectivity -- Sigma imaging agents -- Medicinal chemistry -- 3-dimensional homology models of Sigma1 -- Neuronal plasticity and ion channels -- Opioid receptors and other GPCR -- Cancer -- Neurodegenerative diseases -- Pain -- Cognition, learning, neurological disorders -- Drug abuse and addiction -- Alcohol Abuse -- Stroke and neuroprotection.

Two sigma receptor subtypes have been proposed, sigma1 and 2. Much of our understanding of this system is based on biochemical and pharmacological characterization of the cloned sigma1 receptor subtype (Sigma1) It has become clear that sigma receptors are not canonical receptors. Sigma1 is highly conserved among mammalian species, however, it does not share significant homology with any other mammalian protein. Although a range of structurally diverse small molecules bind Sigma1 with high affinity, and it has been associated with a broad range of signaling systems, Sigma1 itself has no known signaling or enzymatic activity. The evolution of this field over nearly four decades has more recently led to a fundamental shift in the concept of "sigma receptors" to what may more accurately and generally be called sigma proteins. Largely based on traditional pharmacologic approaches, the Sigma1 protein has been associated with a broad range of signaling systems, including G-protein coupled receptors, NMDA receptors, and ion channels. Sigma proteins have been linked to a range of physiological processes, including intracellular calcium signaling, neuroprotection, learning, memory, and cognition. Emerging genetic, clinical, and mechanism focused molecular pharmacology data demonstrate the involvement of proteins in a range of pathophysiologies and disorders including neurodegenerative disease, pain, addiction, psychomotor stimulant abuse, and cancer. However, an understanding of the physiological role of sigma proteins has remained elusive. Emerging data associate Sigma1 with chaperone-like activities or molecular scaffold functions. This book aims to provide an updated perspective on this rapidly evolving field undergoing changes in fundamental concepts of key importance to the discipline of pharmacology. It focusses on the reported roles of sigma proteins in pathophysiology and on emergent therapeutic initiatives.

ISBN: 9783319658537

Standard No.: 10.1007/978-3-319-65853-7doiSubjects--Topical Terms:

1139487
Sigma receptors.

LC Class. No.: RM301.41

Dewey Class. No.: 615.19

Sigma proteins = evolution of the concept of Sigma receptors /
LDR:03430nam a2200325 a 4500 001 904923
003 DE-He213
005 20180419105130.0
006 m d
007 cr nn 008maaau
008 190308s2017 gw s 0 eng d
020 $a 9783319658537 $q (electronic bk.)
020 $a 9783319658513 $q (paper)
024 7 $a 10.1007/978-3-319-65853-7 $2 doi
035 $a 978-3-319-65853-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.41
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
082 0 4 $a 615.19 $2 23
090 $a RM301.41 $b .S577 2017
245 0 0 $a Sigma proteins $h [electronic resource] : $b evolution of the concept of Sigma receptors / $c edited by Felix J. Kim, Gavril W. Pasternak.
260 $a Cham : $c 2017. $b Springer International Publishing : $b Imprint: Springer,
300 $a viii, 330 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.244
505 0 $a Preface -- Historical perspective and background - including Sigma protein subtypes and ligand selectivity -- Sigma imaging agents -- Medicinal chemistry -- 3-dimensional homology models of Sigma1 -- Neuronal plasticity and ion channels -- Opioid receptors and other GPCR -- Cancer -- Neurodegenerative diseases -- Pain -- Cognition, learning, neurological disorders -- Drug abuse and addiction -- Alcohol Abuse -- Stroke and neuroprotection.
520 $a Two sigma receptor subtypes have been proposed, sigma1 and 2. Much of our understanding of this system is based on biochemical and pharmacological characterization of the cloned sigma1 receptor subtype (Sigma1) It has become clear that sigma receptors are not canonical receptors. Sigma1 is highly conserved among mammalian species, however, it does not share significant homology with any other mammalian protein. Although a range of structurally diverse small molecules bind Sigma1 with high affinity, and it has been associated with a broad range of signaling systems, Sigma1 itself has no known signaling or enzymatic activity. The evolution of this field over nearly four decades has more recently led to a fundamental shift in the concept of "sigma receptors" to what may more accurately and generally be called sigma proteins. Largely based on traditional pharmacologic approaches, the Sigma1 protein has been associated with a broad range of signaling systems, including G-protein coupled receptors, NMDA receptors, and ion channels. Sigma proteins have been linked to a range of physiological processes, including intracellular calcium signaling, neuroprotection, learning, memory, and cognition. Emerging genetic, clinical, and mechanism focused molecular pharmacology data demonstrate the involvement of proteins in a range of pathophysiologies and disorders including neurodegenerative disease, pain, addiction, psychomotor stimulant abuse, and cancer. However, an understanding of the physiological role of sigma proteins has remained elusive. Emerging data associate Sigma1 with chaperone-like activities or molecular scaffold functions. This book aims to provide an updated perspective on this rapidly evolving field undergoing changes in fundamental concepts of key importance to the discipline of pharmacology. It focusses on the reported roles of sigma proteins in pathophysiology and on emergent therapeutic initiatives.
650 0 $a Sigma receptors. $3 1139487
650 1 4 $a Biomedicine. $3 593880
650 2 4 $a Neurosciences. $3 593561
650 2 4 $a Human Physiology. $3 668349
650 2 4 $a Human Genetics. $3 593893
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
700 1 $a Kim, Felix J. $3 1171682
700 1 $a Pasternak, Gavril W. $3 782721
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v v.212. $3 882814
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-65853-7
950 $a Biomedical and Life Sciences (Springer-11642)